Sage Journals: Discover world-class research

Retricted access

Research article

First published 2019-12

Tidal peritoneal dialysis versus ultrafiltration in type 1 cardiorenal syndrome: A prospective randomized study

Abdullah K Al-Hwiesh, Ibrahiem Saeed Abdul-Rahman, Nadia Al-Audah [...]

The International Journal of Artificial Organs

Retricted access

Research article

First published 2017-9

Peritoneal Dialysis for the Treatment of Cardiorenal Syndrome Type 1: A Prospective Brazilian Study

Daniela Ponce, Cassiana Góes, Mariele Oliveira [...]

Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis

Free access

Research article

First published 2021-11

Impact of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Renal Function in Type 1 Cardiorenal Syndrome

Daniel T. Ilges, Morgan L. Dermody, Caitlyn Blankenship [...]

Journal of Cardiovascular Pharmacology and Therapeutics

Open access

Research article

First published 2023-03

Syringaresinol inhibits cardiorenal fibrosis through HSP90 in a cardiorenal syndrome type 2

Jianjie Wang, Jianqin Zou, Cheng Zhao [...]

Human & Experimental Toxicology

Open access

Research article

First published 2023

Soluble tumor necrosis factor receptor type 1 predicts cardiorenal outcomes and better associated with distinct cardiovascular or renal outcomes than precedential renal or cardiovascular events in type 2 diabetes mellitus

Li-Hsin Chang, Chia-Huei Chu, Chin-Chou Huang [...]

Therapeutic Advances in Endocrinology and Metabolism

Retricted access

Research article

First published 2013-12

Hypercalcemia Due to Giant Cell Myocarditis: A Case Report

Ami M. Patel, Mariell Jessup, John Tomaszewski [...]

Progress in Transplantation

Open access

Research article

First published 2022

Eplerenone Prevents Cardiac Fibrosis by Inhibiting Angiogenesis in Unilateral Urinary Obstruction Rats

Yi Chang, Ying Ben, Hui Li [...]

Journal of the Renin-Angiotensin-Aldosterone System

Search results

Tidal peritoneal dialysis versus ultrafiltration in type 1 cardiorenal syndrome: A prospective randomized study

Peritoneal Dialysis for the Treatment of Cardiorenal Syndrome Type 1: A Prospective Brazilian Study

Impact of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Renal Function in Type 1 Cardiorenal Syndrome

Syringaresinol inhibits cardiorenal fibrosis through HSP90 in a cardiorenal syndrome type 2

Soluble tumor necrosis factor receptor type 1 predicts cardiorenal outcomes and better associated with distinct cardiovascular or renal outcomes than precedential renal or cardiovascular events in type 2 diabetes mellitus

Hypercalcemia Due to Giant Cell Myocarditis: A Case Report

Eplerenone Prevents Cardiac Fibrosis by Inhibiting Angiogenesis in Unilateral Urinary Obstruction Rats